HRK Antikörper
-
- Target Alle HRK Antikörper anzeigen
- HRK (Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HRK Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Synthetic peptide of human HRK
- Isotyp
- IgG
-
anti-Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK) (AA 15-50) antibody
HRK Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB04688 unconjugated
anti-Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK) (AA 1-50) antibodyHRK Reaktivität: Maus, Ratte ELISA, IF (cc), IF (p), IHC (p), IHC (fro), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK) (N-Term) antibodyHRK Reaktivität: Human, Kaninchen, Rind (Kuh), Hund, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
anti-Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK) (N-Term) antibodyHRK Reaktivität: Human, Maus, Ratte, Kaninchen, Rind (Kuh), Hund WB Wirt: Kaninchen Polyclonal unconjugated
anti-Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK) (BH3 Domain) antibodyHRK Reaktivität: Human, Maus IHC, WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- IHC 1:100-1:300
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- HRK (Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK))
- Andere Bezeichnung
- HRK (HRK Produkte)
- Hintergrund
- This gene encodes a member of the BCL-2 protein family. Members of this family are involved in activating or inhibiting apoptosis. The encoded protein localizes to intracellular membranes. This protein promotes apoptosis by interacting with the apoptotic inhibitors BCL-2 and BCL-X(L) via its BH3 domain. Alternate splicing results in multiple transcript variants.
- NCBI Accession
- NP_003797
- UniProt
- O00198
-
